Global Bifurcation Lesions Market to Reach $4.02 Billion by 2029, Growing at 8.9% CAGR

What industry-specific factors are fueling the growth of the bifurcation lesions market?
The surge in the elderly population is forecasted to stimulate the bifurcation lesions market. Individuals who are over 60 years old have a higher prevalence of experiencing a heart attack, stroke, or contracting coronary heart disease and heart failure than those who are younger. Bifurcation lesions are crucial in such instances as they help in treating blood clots thus ensuring sufficient blood supply to the heart. For example, a report released by the World Health Organization (WHO) in October 2022 projects that by 2030, one in every six individuals globally will be 60 or older. Further, by 2050, the global population of those aged 60 or older will stand at 2.1 billion. The population of people aged 80 or older will grow by 426 million between 2020 and 2050, relative to the existing population. Hence, the rising elderly population will spearhead the growth of the bifurcation lesions market.

Get Your Bifurcation Lesions Market Report Here:
https://www.thebusinessresearchcompany.com/report/bifurcation-lesions-global-market-report

What Is the projected market size and growth rate for the bifurcation lesions market?
The market size for bifurcation lesions has seen a robust expansion in the past years. The growth is forecasted to increase from $2.63 billion in 2024 to $2.86 billion in 2025, with a projected compound annual growth rate (CAGR) of 8.5%. The historical growth is due to an increase in coronary artery diseases, a surge in the elderly population, growth in healthcare spending, and economic progress.

In the upcoming years, the bifurcation lesions market size is predicted to witness robust growth. By 2029, it is projected to reach $4.02 billion, with an 8.9% compound annual growth rate (CAGR). This growth during the forecast period can be tied back to a growing demand for minimally invasive surgical procedures, expansion in healthcare infrastructure and facilities, a rising incidence of cardiovascular diseases, and governmental health policies. Key trends during this forecast period involve approaches that center around the patient, the use of bioresorbable stents, the integration of artificial intelligence and machine learning, as well as cross-disciplinary collaboration.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7414&type=smp

What new trends are reshaping the bifurcation lesions market and its opportunities?
The development of imaging and procedural devices is a significant trend that is becoming increasingly prevalent in the bifurcation lesions market. Big players in the sector are focusing their resources on technological improvements to existing instruments used in imaging and procedures. As an example, Advanced Bifurcation Systems (ABS), a medical device firm in its clinical trial phase that offers a unique stenting solution for consistent treatment of all types of bifurcation lesions during coronary angioplasties, has developed a technology that features the only self-aligning stent module capable of uniformly structuring bifurcations. This platform by ABS presents a distinctive, streamlined system that reduces the necessity for recurrent procedures, thus facilitating effective bifurcation stenting treatments.

What major market segments define the scope and growth of the bifurcation lesions market?
The bifurcation lesions market covered in this report is segmented -

1) By Types: One-Stent, Two-Stent
2) By Application: Coronary Vascular, Peripheral Vascular

Subsegments:
1) By One-Stent: Single-Stent Deployment, Balloon-Expandable Stents, Self-Expanding Stents
2) By Two-Stent: Crush Technique, T- or Y-Configuration Stenting, Side Branch Stenting Techniques

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7414

Which region dominates the bifurcation lesions market?
North America was the largest region in the bifurcation lesions market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bifurcation lesions market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Which key market leaders are driving the bifurcation lesions industry growth?
Major companies operating in the bifurcation lesions market include Boston Scientific Corporation, Terumo Medical Corporation, Spectranetics Corporation, Medtronic plc, Cardinal Health Inc., Cardinal Health Company, Abbott Laboratories, Biosensors International Group Ltd., B. Braun Melsungen AG, Cook Medical LLC, Cordis Corporation, Endologix Inc., W. L. Gore & Associates Inc., InspireMD Inc., MicroPort Scientific Corporation, OrbusNeich Medical Company Limited, Biotronik SE & Co. KG, Cardionovum GmbH, Elixir Medical Corporation, Medinol Ltd., Meril Life Sciences Pvt. Ltd., Opto Circuits (India) Ltd., QualiMed Innovative Medizinprodukte GmbH, Sahajanand Medical Technologies Pvt. Ltd., Svelte Medical Systems Inc., Translumina GmbH, Vascular Concepts Limited, Vascular Solutions Inc., Veryan Medical Ltd., X-Cell Medical Inc., Zorion Medical Inc., Amaranth Medical Inc., Cardiomind Inc., Cardiva Medical Inc.

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=7414&type=smp

What Is Covered In The Bifurcation Lesions Global Market Report?

•Market Size Forecast: Examine the bifurcation lesions market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the bifurcation lesions market for a structured understanding.
•Key Players Overview: Analyze major players in the bifurcation lesions market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the bifurcation lesions market.
•Segment Contributions: Evaluate how different segments drive overall growth in the bifurcation lesions market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the bifurcation lesions market.
•Industry Challenges: Identify potential risks and obstacles affecting the bifurcation lesions market.
•Competitive Landscape: Review strategic developments in the bifurcation lesions market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.